Anil Kumar Chekuri, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dysautonomia, Familial | 4 | 2024 | 95 | 1.420 |
Why?
|
| Retinal Degeneration | 4 | 2023 | 414 | 1.310 |
Why?
|
| Optic Nerve Diseases | 1 | 2022 | 327 | 0.650 |
Why?
|
| DNA Topoisomerases, Type II | 2 | 2016 | 121 | 0.620 |
Why?
|
| Retinal Ganglion Cells | 1 | 2022 | 771 | 0.560 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 1060 | 0.560 |
Why?
|
| Retinal Diseases | 1 | 2019 | 683 | 0.430 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2906 | 0.410 |
Why?
|
| Collagen | 1 | 2019 | 2684 | 0.380 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2018 | 2842 | 0.370 |
Why?
|
| Antigens, Nuclear | 2 | 2016 | 192 | 0.230 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2016 | 441 | 0.210 |
Why?
|
| Membrane Proteins | 1 | 2019 | 7873 | 0.200 |
Why?
|
| DNA-Binding Proteins | 2 | 2016 | 9639 | 0.190 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17400 | 0.180 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2023 | 302 | 0.180 |
Why?
|
| Mutation | 4 | 2023 | 29717 | 0.170 |
Why?
|
| HIV-1 | 1 | 2016 | 6934 | 0.160 |
Why?
|
| Antidiuretic Agents | 1 | 2017 | 24 | 0.160 |
Why?
|
| Gene Targeting | 1 | 2021 | 880 | 0.150 |
Why?
|
| Homozygote | 2 | 2021 | 1777 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 2024 | 5019 | 0.150 |
Why?
|
| Electroretinography | 1 | 2019 | 509 | 0.150 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 236 | 0.140 |
Why?
|
| RNA Splicing | 1 | 2021 | 907 | 0.140 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2016 | 88 | 0.140 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2016 | 127 | 0.130 |
Why?
|
| Macular Degeneration | 1 | 2023 | 980 | 0.130 |
Why?
|
| Mice | 8 | 2024 | 81045 | 0.120 |
Why?
|
| Neuropeptide Y | 1 | 2015 | 200 | 0.120 |
Why?
|
| Dependovirus | 1 | 2019 | 706 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 18006 | 0.110 |
Why?
|
| HEK293 Cells | 3 | 2021 | 4200 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2203 | 0.100 |
Why?
|
| HeLa Cells | 1 | 2018 | 3127 | 0.100 |
Why?
|
| Animals | 12 | 2024 | 168561 | 0.100 |
Why?
|
| Retina | 2 | 2023 | 2611 | 0.100 |
Why?
|
| Metformin | 1 | 2017 | 829 | 0.090 |
Why?
|
| Cerebellum | 2 | 2015 | 1490 | 0.090 |
Why?
|
| Pedigree | 1 | 2018 | 4646 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2017 | 891 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1782 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2019 | 3420 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1675 | 0.080 |
Why?
|
| Virus Replication | 1 | 2016 | 2531 | 0.080 |
Why?
|
| Alleles | 1 | 2018 | 6931 | 0.070 |
Why?
|
| Tomography, Optical Coherence | 1 | 2019 | 2637 | 0.070 |
Why?
|
| Glucose | 1 | 2017 | 4391 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11363 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2014 | 2440 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2021 | 1526 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14554 | 0.060 |
Why?
|
| Gait Ataxia | 1 | 2023 | 12 | 0.060 |
Why?
|
| Kinetin | 1 | 2023 | 21 | 0.060 |
Why?
|
| Peripheral Nervous System | 1 | 2024 | 150 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4465 | 0.050 |
Why?
|
| DNA Repair | 1 | 2011 | 2042 | 0.050 |
Why?
|
| Humans | 11 | 2024 | 742088 | 0.050 |
Why?
|
| Sterol Esterase | 1 | 2021 | 37 | 0.050 |
Why?
|
| Apoptosis | 1 | 2017 | 9715 | 0.050 |
Why?
|
| Phenotype | 1 | 2019 | 16331 | 0.050 |
Why?
|
| Phenethylamines | 1 | 2021 | 101 | 0.050 |
Why?
|
| DNA | 1 | 2015 | 7289 | 0.050 |
Why?
|
| Gene Expression | 2 | 2024 | 7790 | 0.040 |
Why?
|
| Pyridazines | 1 | 2021 | 201 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 16665 | 0.040 |
Why?
|
| Sensory Receptor Cells | 1 | 2024 | 487 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 437 | 0.040 |
Why?
|
| Aging | 1 | 2015 | 8626 | 0.030 |
Why?
|
| Culture Media | 1 | 2017 | 902 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2017 | 759 | 0.030 |
Why?
|
| Exons | 1 | 2021 | 2431 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2023 | 3913 | 0.030 |
Why?
|
| Rats | 3 | 2017 | 24265 | 0.030 |
Why?
|
| Neurons | 1 | 2011 | 9325 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 987 | 0.030 |
Why?
|
| tau Proteins | 1 | 2021 | 1860 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2015 | 1902 | 0.020 |
Why?
|
| Multigene Family | 1 | 2014 | 1102 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 556 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2723 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 474 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 2003 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3518 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3770 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9735 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2017 | 2968 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 9410 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2015 | 19223 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 213127 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2011 | 589 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 2797 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 8300 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 1937 | 0.020 |
Why?
|
| Male | 2 | 2018 | 349538 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2017 | 23387 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3504 | 0.010 |
Why?
|
| Female | 1 | 2018 | 379592 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12071 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10472 | 0.010 |
Why?
|